Article
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours
28 Feb 2019
Abstract excerpt
BACKGROUND: Use of cyclin D1 (CCND1) gene amplification as a breast cancer biomarker has been hampered by conflicting assessments of the relationship between cyclin D1 protein levels and patient survival. Here, we aimed to clarify its prognostic and treatment predictive potential through comprehensive long-term survival analyses. METHODS: CCND1 amplification was assessed using SNP arrays from two cohorts of 1965...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
